Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2018

View Archived Issues

Positive data presented from SEQUOIA and CEDAR phase III studies of abicipar

Transgenic mouse model useful to study the hypersensitivity reactions of abacavir

Phase IIa study of BT-063 for the treatment of SLE meets primary endpoint

Gritstone Oncology to test GRANITE-001 with Opdivo and Yervoy

Membrane findings point to new antimalarial strategies

Sending live phages after deadly lung infections

The Yang to KRAS' Yin?

First biomarker for liver injury from biologic

AT: all bad for platelets

Aevi presents AEVI-004, novel co-crystal version of AEVI-001

UCT-943, a next-generation PI4K inhibitor antimalarial agent: Preclinical profile

Wakamoto completes phase II trial of WP-1303

BeiGene reports preliminary phase II topline data for tislelizumab in classical Hodgkin's lymphoma

FDA grants approval to Tibsovo for relapsed/refractory AML with IDH1 mutation

UCB Pharma divulges UDP/CysLT receptor modulators

Researchers find IL-6 levels tied to worse prognosis in ESCC patients

New G protein-coupled receptor 39 agonists patented by Daiichi Sankyo

INSERM and collaborators describe lactic acid bacteria compositions

Samsung Life Public Welfare Foundation creates siRNAs specific to the SS18-SSX fusion gene

ShanghaiTech University synthesizes PIWIL4 inhibitors

New phase I study evaluates MK-4830 alone and with pembrolizumab for advanced solid tumors

FDA approves single-dose Krintafel for radical cure of P. vivax malaria

Asceneuron presents phase I results for ASN-120290

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...